Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca ...

said in a statement that the decision was "important not only for lowering asthma inhaler costs, it also sets the stage for removal of junk listings on a range of other critical medications." ...

While many factors play a role in the onset of symptoms, frigid weather makes it especially difficult to breathe for people ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

While inhalers are lifesavers for asthma patients, they carry a hidden environmental cost. Dr Bwika explains, “Inhalers are just devices useful in the delivery of drugs into the body.

Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...